arrow
O

Oskar Hansson

Lund University
H指数:143
被引数:8.3万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Locus coeruleus activity is related to sleep and 24-h rest-activity rhythms in the context of plasma Alzheimer’s disease markers: a 7T MRI study of older individuals

蓝斑活动与血浆阿尔茨海默病标志物背景下的睡眠和24小时休息-活动节律相关:一项针对老年人的7T MRI研究

2026-10-010
OA
Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine‐related dysfunction on tau and its impact on cognition

星形胶质细胞反应性改变了蓝斑去甲肾上腺素相关功能障碍对tau及其对认知影响的作用

2026-08-050
OA
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias

血浆蛋白质组分析确定了神经退行性痴呆的鉴别诊断疾病和分子分期的生物标志物

2026-07-200
OAAI
Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial

人源胚胎干细胞来源的多巴胺能细胞用于帕金森病:一项1/2期开放标签试验

2026-07-090
OAAI
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females

Tau-PET和CSF MTBR-tau243比较证实女性中tau聚集增加

2026-05-270
OAAI
Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts

基于语音的数字认知评估在临床试验中的应用:检测欧洲人群认知障碍阶段与AD生物标志物关系

2026-05-180
OA
Turning as a single and dual task—associations with Alzheimer’s and vascular pathologies in cognitively healthy older people

转身作为单一和双重任务——与认知健康老年人中阿尔茨海默病和血管病理的关联

2026-05-070
OAAI
Association Between Fatigue, Information Processing Speed and Plasma Levels of Glial Fibrillary Acidic Protein and Neurofilament Light in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Natalizumab or Rituximab

复发缓解型多发性硬化患者中疲劳、信息处理速度与胶质纤维酸性蛋白和神经丝蛋白轻链血浆水平的相关性:纳他珠单抗或利妥昔单抗治疗的研究

2026-04-290
OAAI
Neuropathological correlates of age and sex differences in 18F-flortaucipir PET

18F-氟多巴胺标记的PET成像中年龄和性别差异的神经病理学相关性

Brain
IF11.7
2026-04-200
OA
Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer’s disease continuum

血浆和脑脊液中MTBR-tau243及磷酸化-tau蛋白物种在阿尔茨海默病连续谱中的轨迹

2026-04-090
OAAI
Alzheimer's disease Stage 1 and 2: Biology, diagnostics, and treatment

阿尔茨海默病第1和第2阶段:生物学、诊断和治疗

2026-03-120
OAAI
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units

基于联合传播模型的外部验证Tau PET CenTauR单位

2026-01-080
OA
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology

一种微创的干血斑生物标志物检测方法,用于检测阿尔茨海默病的病理学

2026-01-050
OAAI
Assessment of myocardial sympathetic innervation with [123I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera.

评估心肌交感神经支配情况,使用[123I]mIBG心肌闪烁显像:Anger型与环状配置的碲化镉锌伽马相机比较研究。

2025-11-270
OAAI
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

血清p-tau217在阿尔茨海默病中的诊断价值:其水平与临床实用性是否等同于血浆?

2025-11-010
PRE